IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 42 filers reported holding IMMUNOCORE HLDGS PLC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,669,648 | +81.7% | 301,920 | +109.9% | 0.02% | +90.0% |
| Q2 2023 | $8,624,287 | +81.2% | 143,834 | +49.4% | 0.01% | +66.7% |
| Q1 2023 | $4,758,748 | -10.2% | 96,253 | +3.6% | 0.01% | -14.3% |
| Q4 2022 | $5,302,145 | +43.8% | 92,906 | +15.5% | 0.01% | +40.0% |
| Q3 2022 | $3,686,000 | +259.3% | 80,406 | +192.3% | 0.01% | +400.0% |
| Q2 2022 | $1,026,000 | +24.8% | 27,506 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $822,000 | -12.7% | 27,506 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $942,000 | -7.6% | 27,506 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $1,020,000 | +13.3% | 27,506 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $900,000 | -23.1% | 27,506 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $1,171,000 | – | 27,506 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $21,400,000 | 6.26% |
| Rock Springs Capital Management LP | 2,445,155 | $90,642,000 | 1.91% |
| Avidity Partners Management LP | 1,095,600 | $40,614,000 | 0.90% |
| Bain Capital Public Equity Management II, LLC | 638,205 | $23,658,000 | 0.83% |
| RTW INVESTMENTS, LP | 1,245,532 | $46,172,000 | 0.70% |
| Baker Brothers Advisors | 2,520,730 | $93,443,000 | 0.41% |
| Samsara BioCapital, LLC | 64,000 | $2,372,000 | 0.37% |
| Pier Capital, LLC | 78,514 | $2,911,000 | 0.30% |
| Rhenman & Partners Asset Management AB | 90,000 | $3,336,000 | 0.23% |
| Perceptive Advisors | 400,000 | $14,828,000 | 0.22% |